Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics
Key Takeaways
Researchers performed a retrospective chart review to explore predictors of 1-year rehospitalization in patients with bipolar I disorder treated with atypical antipsychotics (AAP). All candidates were followed up for 1 year and subdivided into three AAP treatment groups (olanzapine, risperidone, and quetiapine group). The study included 138 participants, and a 1-year rehospitalization rate was 18.1%. There were no variations in time to rehospitalization between three AAP treatment groups. A family history of depression and a number of prior admissions were predictors of rehospitalization due to any episode within 1 year. The results will help explain prognosis and predict the likelihood of rehospitalization in patients with bipolar disorder on AAP.
Read the full article on International Clinical Psychopharmacology.